Quantitative Analyses and Kinetic Modelling in Nuclear Medicine: Publications
Publications 2024
SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [177Lu]Lu-DOTATATE
J Nucl Med, 65 (5), 753-760
DOI 10.2967/jnumed.123.266843, PubMed 38548350
Do we need dosimetry for optimization of theranostics in CNS tumors?
Neuro Oncol (in press)
DOI 10.1093/neuonc/noae200, PubMed 39351795
Understanding individual variability in opioid responses: A call to arms
Addict Biol, 29 (6), e13418
DOI 10.1111/adb.13418, PubMed 38853701
Factors associated with use of opioid rescue medication after surgery
Reg Anesth Pain Med, 49 (4), 265-271
DOI 10.1136/rapm-2023-104412, PubMed 37479238
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials
Eur J Nucl Med Mol Imaging, 51 (5), 1268-1286
DOI 10.1007/s00259-024-06640-x, PubMed 38366197
Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine
Eur J Nucl Med Mol Imaging (in press)
DOI 10.1007/s00259-024-06853-0, PubMed 39133306
Hyperalgesia in Patients With a History of Opioid Use Disorder: A Systematic Review and Meta-Analysis
JAMA Psychiatry (in press)
DOI 10.1001/jamapsychiatry.2024.2176, PubMed 39141367
Publications 2023
Use of ionizing radiation in a Norwegian cohort of children with congenital heart disease: imaging frequency and radiation dose for the Health Effects of Cardiac Fluoroscopy and Modern Radiotherapy in Pediatrics (HARMONIC) study
Pediatr Radiol, 53 (12), 2502-2514
DOI 10.1007/s00247-023-05774-8, PubMed 37773444
Imaging the tumour microenvironment in rectal cancer: Decline in tumour blood flow during radiotherapy predicts good outcome
Phys Imaging Radiat Oncol, 25, 100417
DOI 10.1016/j.phro.2023.100417, PubMed 36718357
Correlations between [68Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [177Lu]Lu-DOTA-TATE
Cancers (Basel), 15 (4)
DOI 10.3390/cancers15041134, PubMed 36831477
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update
Semin Nucl Med, 53 (3), 413-425
DOI 10.1053/j.semnuclmed.2022.12.006, PubMed 36635112
Opioid analgesic effects on subjective well-being in the operating theatre
Anaesthesia, 78 (9), 1102-1111
DOI 10.1111/anae.16069, PubMed 37381617
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry
Eur J Nucl Med Mol Imaging, 50 (9), 2595-2604
DOI 10.1007/s00259-023-06215-2, PubMed 37129712
EANM enabling guide: how to improve the accessibility of clinical dosimetry
Eur J Nucl Med Mol Imaging, 50 (7), 1861-1868
DOI 10.1007/s00259-023-06226-z, PubMed 37086275
Correction to: EANM enabling guide: how to improve the accessibility of clinical dosimetry
Eur J Nucl Med Mol Imaging, 50 (10), 3157-3158
DOI 10.1007/s00259-023-06304-2, PubMed 37382664
Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis
Front Med (Lausanne), 10, 1058914
DOI 10.3389/fmed.2023.1058914, PubMed 36844217
Traceable calibration with 177Lu and comparison of activity meters at hospitals in Norway and Sweden
Phys Med, 116, 103170
DOI 10.1016/j.ejmp.2023.103170, PubMed 37989044
Time-Activity data fitting in molecular Radiotherapy: Methodology and pitfalls
Phys Med, 117, 103192
DOI 10.1016/j.ejmp.2023.103192, PubMed 38052710
Imaging of 212Pb in mice with a clinical SPECT/CT
EJNMMI Phys, 10 (1), 47
DOI 10.1186/s40658-023-00571-6, PubMed 37603123
Optimization of Q.Clear reconstruction for dynamic 18F PET imaging
EJNMMI Phys, 10 (1), 65
DOI 10.1186/s40658-023-00584-1, PubMed 37861929
Optimized SPECT Imaging of 224Ra α-Particle Therapy by 212Pb Photon Emissions
J Nucl Med, 64 (7), 1131-1137
DOI 10.2967/jnumed.122.264455, PubMed 37268424
Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation
Leukemia, 37 (10), 2107-2114
DOI 10.1038/s41375-023-01998-7, PubMed 37568010
Implementation of dosimetry for molecular radiotherapy; results from a European survey
Phys Med, 117, 103196
DOI 10.1016/j.ejmp.2023.103196, PubMed 38104033
EFOMP policy statement NO. 19: Dosimetry in nuclear medicine therapy - Molecular radiotherapy
Phys Med, 116, 103166
DOI 10.1016/j.ejmp.2023.103166, PubMed 37926641
New nuclear medicine diagnostic method for parathyroid
Tidsskr Nor Laegeforen, 143 (18)
DOI 10.4045/tidsskr.23.0701, PubMed 38088295
MR elastography identifies regions of extracellular matrix reorganization associated with shorter survival in glioblastoma patients
Neurooncol Adv, 5 (1), vdad021
DOI 10.1093/noajnl/vdad021, PubMed 37066109
Publications 2022
Quantitative SPECT/CT imaging of lead-212: a phantom study
EJNMMI Phys, 9 (1), 52
DOI 10.1186/s40658-022-00481-z, PubMed 35925521
Correction to: Quantitative SPECT/CT imaging of lead-212: a phantom study
EJNMMI Phys, 9 (1), 71
DOI 10.1186/s40658-022-00499-3, PubMed 36214932
Scar imaging in the dyssynchronous left ventricle: Accuracy of myocardial metabolism by positron emission tomography and function by echocardiographic strain
Int J Cardiol, 372, 122-129
DOI 10.1016/j.ijcard.2022.11.042, PubMed 36460211
FDG PET/CT and Dosimetric Studies of 177Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma-Are We Hitting the Target?
Mol Imaging Biol, 24 (5), 807-817
DOI 10.1007/s11307-022-01731-3, PubMed 35486292
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma
Blood, 139 (12), 1863-1877
DOI 10.1182/blood.2021012852, PubMed 34932792
Evaluation of semi-quantitative measures of 18F-flutemetamol PET for the clinical diagnosis of Alzheimer's disease
Quant Imaging Med Surg, 12 (1), 493-509
DOI 10.21037/qims-21-188, PubMed 34993096
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
Eur J Nucl Med Mol Imaging, 49 (6), 1778-1809
DOI 10.1007/s00259-022-05727-7, PubMed 35284969
Radionuclides for Targeted Therapy: Physical Properties
Molecules, 27 (17)
DOI 10.3390/molecules27175429, PubMed 36080198
Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
Mol Imaging Biol, 24 (5), 842-851
DOI 10.1007/s11307-022-01734-0, PubMed 35501622
Publications 2021
Myelosuppression in patients treated with 177Lutetium-lilotomab satetraxetan can be predicted with absorbed dose to the red marrow as the only variable
Acta Oncol, 60 (11), 1481-1488
DOI 10.1080/0284186X.2021.1959635, PubMed 34425735
A Pilot Study of a Parent Emotion Socialization Intervention: Impact on Parent Behavior, Child Self-Regulation, and Adjustment
Front Psychol, 12, 730278
DOI 10.3389/fpsyg.2021.730278, PubMed 34721193
EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres
EJNMMI Phys, 8 (1), 77
DOI 10.1186/s40658-021-00394-3, PubMed 34767102
Left ventricular regional glucose metabolism in combination with septal scar extent identifies CRT responders
Eur J Nucl Med Mol Imaging, 48 (8), 2437-2446
DOI 10.1007/s00259-020-05161-7, PubMed 33416956
Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and 18F-FDG Positron Emission Tomography/CT in Clinically Progressive Disease
Front Immunol, 11, 617985
DOI 10.3389/fimmu.2020.617985, PubMed 33584710
Publications 2020
Discovery of a Lead Brain-Penetrating Gonadotropin-Releasing Hormone Receptor Antagonist with Saturable Binding in Brain
ChemMedChem, 15 (17), 1624-1628
DOI 10.1002/cmdc.202000256, PubMed 32677155
EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours
EJNMMI Phys, 7 (1), 15
DOI 10.1186/s40658-020-0282-7, PubMed 32144574
Regional myocardial work by cardiac magnetic resonance and non-invasive left ventricular pressure: a feasibility study in left bundle branch block
Eur Heart J Cardiovasc Imaging, 21 (2), 143-153
DOI 10.1093/ehjci/jez231, PubMed 31599327
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma
Eur J Nucl Med Mol Imaging, 48 (6), 1902-1914
DOI 10.1007/s00259-020-05098-x, PubMed 33196921
Publications 2019
Comparison of Intravoxel incoherent motion imaging and multiecho dynamic contrast-based MRI in rectal cancer
J Magn Reson Imaging, 50 (4), 1114-1124
DOI 10.1002/jmri.26740, PubMed 30945379
A Nordic survey of CT doses in hybrid PET/CT and SPECT/CT examinations
EJNMMI Phys, 6 (1), 24
DOI 10.1186/s40658-019-0266-7, PubMed 31845047
Intact responses to non-drug rewards in long-term opioid maintenance treatment
Neuropsychopharmacology, 44 (8), 1456-1463
DOI 10.1038/s41386-019-0377-9, PubMed 30928994
Effects of opioid receptor stimulation and blockade on touch pleasantness: a double-blind randomised trial
Soc Cogn Affect Neurosci, 14 (4), 411-422
DOI 10.1093/scan/nsz022, PubMed 30951167
Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic
PLoS One, 14 (8), e0221365
DOI 10.1371/journal.pone.0221365, PubMed 31430334
The role of the opioid system in decision making and cognitive control: A review
Cogn Affect Behav Neurosci, 19 (3), 435-458
DOI 10.3758/s13415-019-00710-6, PubMed 30963411
Re: Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma
J Vasc Interv Radiol, 30 (12), 2047-2048
DOI 10.1016/j.jvir.2019.08.030, PubMed 31676203
Publications 2018
The Effect of New Formulas for Lean Body Mass on Lean-Body-Mass-Normalized SUV in Oncologic 18F-FDG PET/CT
J Nucl Med Technol, 46 (3), 253-259
DOI 10.2967/jnmt.117.204586, PubMed 29599401
Striatal dopamine deficits predict reductions in striatal functional connectivity in major depression: a concurrent 11C-raclopride positron emission tomography and functional magnetic resonance imaging investigation
Transl Psychiatry, 8 (1), 264
DOI 10.1038/s41398-018-0316-2, PubMed 30504860
Morphine reduced perceived anger from neutral and implicit emotional expressions
Psychoneuroendocrinology, 91, 123-131
DOI 10.1016/j.psyneuen.2018.02.035, PubMed 29550675
Low dose-rate irradiation with [3H]-labelled valine to selectively target hypoxic cells in a human colorectal cancer xenograft model
Acta Oncol, 57 (9), 1216-1224
DOI 10.1080/0284186X.2018.1457223, PubMed 29630428
Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients
Eur J Nucl Med Mol Imaging, 45 (7), 1233-1241
DOI 10.1007/s00259-018-3964-9, PubMed 29470615
Publications 2017
Respiratory motion during 90Yttrium PET contributes to underestimation of tumor dose and overestimation of normal liver tissue dose
Acta Radiol, 59 (2), 132-139
DOI 10.1177/0284185117710052, PubMed 28509566
Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody-Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan
J Nucl Med, 59 (4), 704-710
DOI 10.2967/jnumed.117.195347, PubMed 28848035
Biodistribution and Radiation Dosimetry of 18F-FTC-146 in Humans
J Nucl Med, 58 (12), 2004-2009
DOI 10.2967/jnumed.117.192641, PubMed 28572487
100 days with scans of the same Catphan phantom on the same CT scanner
J Appl Clin Med Phys, 18 (6), 224-231
DOI 10.1002/acm2.12186, PubMed 28921910
Combining radioiodine and external beam radiation therapy: the potential of integrated treatment planning for differentiated thyroid cancer
Acta Oncol, 56 (6), 894-897
DOI 10.1080/0284186X.2017.1286384, PubMed 28464741
Radiosynthesis and First-In-Human PET/MRI Evaluation with Clinical-Grade [18F]FTC-146
Mol Imaging Biol, 19 (5), 779-786
DOI 10.1007/s11307-017-1064-z, PubMed 28280965
Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey
EJNMMI Phys, 4 (1), 28
DOI 10.1186/s40658-017-0193-4, PubMed 29199391
Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force
EJNMMI Phys, 4 (1), 27
DOI 10.1186/s40658-017-0194-3, PubMed 29164483
Publications 2016
Red Marrow-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with 177Lu-Lilotomab Satetraxetan, a Novel Anti-CD37 Antibody-Radionuclide Conjugate
J Nucl Med, 58 (1), 55-61
DOI 10.2967/jnumed.116.180471, PubMed 27587710
Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan
J Nucl Med, 58 (1), 48-54
DOI 10.2967/jnumed.116.173922, PubMed 27493270